Clinical Trial Update: Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the pharmacokinetics of tenofovir disoproxil fumarate 300 mg in healthy Chinese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED